Covered recipient · General Payments record
SARADA GUMMADI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$1,015.04
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $353.86 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $81.39 | 4 |
| EISAI INC. | $60.13 | 3 |
| Gilead Sciences, Inc. | $53.44 | 3 |
| Genentech USA, Inc. | $49.16 | 2 |
| GlaxoSmithKline, LLC. | $46.42 | 3 |
| PFIZER INC. | $46.05 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc. | $17.35 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089429047 | CMS |
| Daiichi Sankyo Inc. | $22.28 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089429049 | CMS |
| Daiichi Sankyo Inc. | $18.04 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089429043 | CMS |
| Daiichi Sankyo Inc. | $23.72 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089429045 | CMS |
| Eisai Inc. | $14.15 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110779970 | CMS |
| Eisai Inc. | $24.92 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110779972 | CMS |
| Eisai Inc. | $21.06 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110779968 | CMS |
| Genentech USA, Inc. | $25.89 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133107531 | CMS |
| Genentech USA, Inc. | $23.27 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133107534 | CMS |
| Gilead Sciences, Inc. | $15.34 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133803516 | CMS |
| Gilead Sciences, Inc. | $23.81 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133803518 | CMS |
| Gilead Sciences, Inc. | $14.29 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133803520 | CMS |
| GlaxoSmithKline, LLC. | $13.91 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116281735 | CMS |
| GlaxoSmithKline, LLC. | $17.96 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116146411 | CMS |
| GlaxoSmithKline, LLC. | $14.55 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116307575 | CMS |
| Novartis Pharmaceuticals Corporation | $17.27 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086927185 | CMS |
| PFIZER INC. | $15.62 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131290338 | CMS |
| PFIZER INC. | $14.72 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131291786 | CMS |
| PFIZER INC. | $15.71 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131306855 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.